Guest Open Access Plus | Free Content | About | Sign in | New Users: Sign up | Mark List  

Current Topics in Medicinal Chemistry

Volume 12 Issue 5
ISSN: 1568-0266
eISSN: 1873-5294


   All Titles

  Reversed Chloroquine Molecules as a Strategy to Overcome Resistance in Malaria
  pp.400-407 (8) Author: David H. Peyton

This short review tells the story of how Reversed Chloroquine drugs (RCQs) were developed. These are hybrid molecules, made by combining the quinoline nucleus from chloroquine (CQ) with moieties which are designed to inhibit efflux via known transporters in the membrane of the digestive vacuole of the malaria parasite. The resulting RCQ drugs can have potencies exceeding that of CQ, while at the same time having physical chemical characteristics that may make them favorable as partner drugs in combination therapies. The need for such novel antimalarial drugs will continue for the foreseeable future.

  Keywords: Antimalarial, chloroquine, Plasmodium falciparum, drug development, drug design, structure activity relationship, malaria, drug resistance, Reversed Chloroquine drugs (RCQs), combination therapies
  Affiliation: Department of Chemistry, Portland State University, Portland, OR 97207-0751.
  Key: New Content Free Content Open Access Plus Subscribed Content

Bentham Science Publishers


  Copyright © 1994 - 2015   Bentham Science Publishers